BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19381042)

  • 1. [A case report of FOLFOX treatment for primary duodenal carcinoma with multiple liver metastases].
    Fujiwara Y; Naomoto Y; Tanabe S; Sakurama K; Noma K; Nishikawa T; Motoki T; Takaoka M; Shirakawa Y; Yamatsuji T; Matsuoka J; Tanaka N
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):655-7. PubMed ID: 19381042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of recurrent duodenal carcinoma successfully controlled with FOLFOX treatment].
    Yasui T; Mukubo H; Nakanuma S; Sato N; Kita I
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1726-8. PubMed ID: 24393902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of advanced gastric cancer effectively treated with combination of weekly paclitaxel and hepatic arterial infusion of 5-FU/LV].
    Oida Y; Motojuku M; Morikawa G; Mukai M; Imaizumi T; Makuuchi H
    Gan To Kagaku Ryoho; 2008 Feb; 35(2):303-6. PubMed ID: 18281770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A CR case of colorectal cancer given 39 courses of FOLFOX].
    Kobayashi K; Kaneko M; Fujiwara M; Otsubo M; Ogura S; Isaka T; Imai N; Naota H; Taniguchi K
    Gan To Kagaku Ryoho; 2009 Jan; 36(1):135-8. PubMed ID: 19151580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A successfully resected case of colorectal cancer with multiple liver metastases treated with FOLFIRI after failure of mFOLFOX6].
    Fukuda H; Tazawa K; Sawada S; Nagata T; Uotani H; Hirokawa S; Yamagishi F; Tsukada K
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):507-9. PubMed ID: 18347406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma.
    Catania C; Pelosi G; Fazio N; Biffi R; Spitaleri G; Noberasco C; Zampino MG; Maggioni A; Trifirò G; Toffalorio F; Vigna PD; De Braud F; De Pas T
    Acta Oncol; 2010; 49(1):120-1. PubMed ID: 20100147
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatic arterial infusion chemotherapy using fluorouracil followed by systemic therapy using oxaliplatin plus fluorouracil and leucovorin for patients with unresectable liver metastases from colorectal cancer.
    Seki H; Ozaki T; Shiina M
    Cardiovasc Intervent Radiol; 2009 Jul; 32(4):679-86. PubMed ID: 19296157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of ascending colon cancer successfully treated for synchronous liver metastases with mFOLFOX6 after a resection of the primary tumor].
    Tomochika S; Hazama S; Nakatsu H; Yoshida S; Tokuhisa Y; Yoshino S; Oka M
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2184-6. PubMed ID: 20037364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of FOLFOX to unresectable liver metastases secondary from colorectal carcinoma in an oncologic emergency.
    Sugimoto M; Yasuda H; Koda K; Yamazaki M; Tezuka T; Takenoue T; Kosugi C; Higuchi R; Yamamoto S; Watayo Y; Yagawa Y; Suzuki M
    Hepatogastroenterology; 2007 Sep; 54(78):1684-8. PubMed ID: 18019695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOLFOX regimen in pancreatic acinar cell carcinoma: case report and review of the literature.
    Simon M; Bioulac-Sage P; Trillaud H; Blanc JF
    Acta Oncol; 2012 Mar; 51(3):403-5. PubMed ID: 21961498
    [No Abstract]   [Full Text] [Related]  

  • 11. 5-fluorouracil leucovorin and oxaliplatin (FOLFOX) in the treatment of metastatic colon cancer with severe liver dysfunction.
    Fakih MG
    Oncology; 2004; 67(3-4):222-4. PubMed ID: 15557782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with oxaliplatin and 5-fluorouracil in a patient with severe hepatic dysfunction associated with metastatic adenocarcinoma of the large bowel.
    Grenader T; Goldberg A; Gabizon A
    Anticancer Drugs; 2009 Oct; 20(9):845-7. PubMed ID: 19633535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of advanced ascending colon cancer, curatively resected after complete response in left supraclavicular and paraaortic lymph nodes and liver metastases to FOLFOX4 therapy].
    Furumoto K; Kojima H; Takaya H; Okuno M; Fuji H; Mizuno R; Mori T; Ito D; Kogire M
    Gan To Kagaku Ryoho; 2010 Feb; 37(2):323-6. PubMed ID: 20154495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of rectal cancer with liver metastases successfully treated with modified FOLFOX6 therapy].
    Shoji T; Takahashi Y; Matsuda I; Suzuki K; Misumi K; Taniguchi M; Yamazaki M; Yonekawa H
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1579-81. PubMed ID: 19755838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and toxicity of FOLFOX regimen (a combination of leucovorin and fluorouracil with oxaliplatin) as first-line treatment of metastatic colorectal cancer.
    Matsushita H; Tsuboi K; Honda I; Kato N; Okochi O; Kobayashi D; Hattori M
    Gan To Kagaku Ryoho; 2009 May; 36(5):797-801. PubMed ID: 19461180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epiphora in a patient receiving FOLFOX therapy].
    Yatsuda C; Niimi M; Ono Y; Uto N; Iwagami E; Tanaka E; Yamato M
    Gan To Kagaku Ryoho; 2008 Nov; 35(11):1989-91. PubMed ID: 19011359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of locally advanced rectal cancer responding to FOLFOX].
    Kume S; Kubota T; Takahashi M; Hashimoto D; Hirata T; Torigoe Y; Ikeda O
    Gan To Kagaku Ryoho; 2009 Apr; 36(4):659-61. PubMed ID: 19381043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case with liver resection of metastasis from rectal cancer after FOLFOX4+bevacizumab treatment].
    Kojima T; Matsui T; Uemura T; Fujimitsu Y; Kure N; Kojima H
    Gan To Kagaku Ryoho; 2008 Oct; 35(10):1761-3. PubMed ID: 18931584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two cases of interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and Leucovorin (FOLFOX)].
    Ohori H; Takahashi M; Ogasawara N; Suzuki M; Miyate Y; Kato S
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):295-8. PubMed ID: 19223749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiorgan failure in a patient treated with the 5-fluorouracil, leucovorin, oxaliplatin, and irinotecan regimen.
    Schwartzman AD; Sethi R; Smith R
    Clin Colorectal Cancer; 2013 Jun; 12(2):136-9. PubMed ID: 23098664
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.